InvestorsHub Logo
Followers 12
Posts 2781
Boards Moderated 0
Alias Born 03/05/2012

Re: ~ Blue ~ post# 2526

Wednesday, 05/30/2012 12:49:01 PM

Wednesday, May 30, 2012 12:49:01 PM

Post# of 39209
So you're posting the same thing I did now supporting my assertion...

They were REJECTED by the FDA for the 510(k) and have NOTHING in front of them now!! Sheesh. you're tough!

Understanding that the above statements were a fair representation of the regulatory industry's general feelings towards the FDA De Novo process, management decided to accept and heed the FDA's letter (received on August 2, 2011) detailing their decision of CTLM® being “not substantially equivalent” and furthermore, accepting their recommendation that CTLM® is a class III device that would require a PMA submission.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.